BridgeBio Pharma, Inc. ( BBIO) - Key Metrics
BBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.78 | -$1 | -$0.29 | -$0.31 |
| 2025Q3 | $0.63 | -$0.96 | -$0.58 | -$0.58 |
| 2025Q2 | $0.58 | -$0.95 | -$0.42 | -$0.45 |
| 2025Q1 | $0.61 | -$0.88 | -$1.05 | -$1.06 |
BBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -19.12 |
| 2025Q3 | ? | -13.54 |
| 2025Q2 | ? | -11.31 |
| 2025Q1 | ? | -9.82 |
BBIO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -1.36% | ? |
| 2025Q4 | -0.40% | ? |
| 2025Q3 | -1.11% | ? |
| 2025Q2 | -1.04% | ? |
| 2025Q1 | -3.06% | ? |
BBIO
Price: $66.61
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.74 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.7 million
Market Capitalization: 13.2 billion